Pipeline Trigger: Predicta Biosciences $23.4M Series A
Predicta just closed $23.4M Series A. Pitch lab automation to scale pipelines. Close deals faster and boost your commission.
Published on
Do not index
Do not index
🚀 Battle Card: Predicta Biosciences
Quick trigger:
👤 Decision Maker in the News
💡 Why It Matters
- New capital accelerates scaling of non-invasive oncology diagnostics and lab infrastructure, signaling aggressive expansion into precision diagnostics. → Source
🎯 Core Pain Point
- Rapidly scale CLIA lab infrastructure without compromising compliance
- Commercialize GenoPredicta while expanding diagnostic portfolio
💰 What to Pitch
- Primary: Lab automation & integration platform → increase throughput & ensure CLIA compliance
- Expansion: Data analytics & reporting suite → deliver actionable patient insights & differentiation
🗺️ Quick Context
- HQ: Cambridge, MA
- Employees: ≈ 75
- Rev: ≈ $5M
🤼 Competitive Intel
Which other vendors you’ll probably face to win Predicta Biosciences’s business.
- Guardant Health — Liquid biopsy diagnostics
- Unique edge: Widely adopted ctDNA assays
- Evaluated by Dir. R&D for clinical validation
- Foundation Medicine — Comprehensive genomic profiling
- Unique edge: Deep tumor sequencing & FDA approvals
- Evaluated by VP Ops for regulatory fit
- Natera — Molecular diagnostics & testing
- Unique edge: Proven workflow in clinical labs
- Evaluated by Lab Manager for throughput
- Grail — Early cancer detection
- Unique edge: NGS-based multi-cancer early detection
- Evaluated by CMO for pipeline alignment
- Invitae — Genetic testing services
- Unique edge: Comprehensive test menu & payer coverage
- Evaluated by CFO for cost structure
✅ Do-Now Checklist
Connect with Brian McKernan on LinkedIn (link above)
Craft outreach leveraging this Predicta Biosciences sales trigger: highlight lab scale and analytics edge
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Get Predicta Biosciences sales trigger intel like this daily—no fluff, all pipeline.
Subscribe to NewsletterForLeads
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑❑
OFFER_BRIEF = ❑Lab automation & integration platform❑
PROOF_METRIC = ❑40% throughput boost❑
CTA_STYLE = ❑quick_call❑
TONE = ❑punchy❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Brian
COMPANY = Predicta Biosciences
DEPT = Ops & Supply Chain
SIZE = ≈10
BOTTLENECK = Rapidly scaling CLIA lab infrastructure without compliance risks
EVENT = $23.4M Series A raise
DETAIL = scale its novel diagnostic platform
PAIN = difficulty scaling CLIA labs without errors or compliance
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20251001161796&div=41152219
SIM_CO = Guardant Health
WIN_METRIC = 40% throughput boost
NEXT_SIZE = ≈20
EMP_EST = ≈75
REV_EST = ≈$5M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: ≈10-person Ops & Supply Chain
Brian—noticed your Ops & Supply Chain team is ≈10.
That’s when Rapidly scaling CLIA lab infrastructure without compliance risks slows growth.
We helped Guardant Health fix this with Lab automation & integration platform.
Result: 40% throughput boost.
Quick call?
PS—next bottleneck hits ≈20.
DM ≤45 words, TONE:
Saw your post about scale its novel diagnostic platform — difficulty scaling CLIA labs without errors or compliance.
Lab automation & integration platform. 40% throughput boost.
Quick chat?